📊 Backtest📒 Journal Updated 14/07/2026
← ⚡ Catalyst
📐 Simulate Position
FRESHReport written today · at $48.96

OKLO

SpeculativeMID CAP
Oklo Inc. · NYSE · Energy / Advanced Nuclear (SMR)
$48.96
▲ 0.35%
MCap $8.5B
Self-fetched today — not yet in live-prices.json cache (new pick this run). Trading near its 52-week low ($44.88) after a 31% YTD slide, largely on DOE's $17.5B large-reactor loan program spooking SMR investors, not on Oklo-specific news.
BusinessAdvanced fission / SMR developer · Aurora powerhouse + Groves isotope test reactor · DOE Reactor Pilot Program fast-track · pre-revenue, targeting first criticality July 2026
Thesis

Oklo's Groves isotope test reactor cleared its final DOE safety review (Documented Safety Analysis approved Jul 1, 2026) and is targeting first criticality — the reactor's first self-sustaining nuclear chain reaction — sometime this month. That's a genuine, near-term, company-specific binary milestone, distinct from the sector-wide DOE large-reactor loan news that dragged the stock down 31% YTD and put it right at its 52-week low. Consensus analyst target ~$86 implies ~76% upside from here, though Guggenheim's Hold-rated $54 target is a real, more conservative counterpoint worth weighing. Pre-revenue and volatile — this is a speculative binary-catalyst play, not a core holding.

📝 Primary Verdict · Core Holding
SPECULATIVESpeculative

SPECULATIVE — buy small ahead of the July criticality target, size up only on a dip toward the 52-week low. This is a genuine binary catalyst distinct from the sector-wide DOE loan-program overhang that crushed the stock in June.

81
score / 100 ⓘ
⚡ Catalyst
⚛️ Groves Reactor First Criticality~2 WEEKS (target)

Oklo's Groves isotope test reactor in Texas cleared DOE's Documented Safety Analysis on Jul 1, 2026 — the last major documentation gate before startup. Remaining steps are DOE's readiness review and startup approval, then fuel load and first criticality (the reactor achieving a controlled, self-sustaining chain reaction for the first time). Company has stated an internal target of achieving this within July 2026, though the exact day is not yet public.

~Jul 2026
📄 DOE Readiness Review + Startup ApprovalONGOING

The remaining procedural gates between the Jul 1 DSA approval and actual criticality — DOE readiness review, then formal startup approval to load fuel. Fast-tracked under the Trump administration's Energy Reactor Pilot Program.

Ongoing
🏗️ Aurora Powerhouse — Commercial Power TargetLATE 2027

Oklo's actual revenue-generating reactor (Idaho National Laboratory) is targeting commercial power by late 2027. Groves is a smaller isotope test reactor, not Aurora — investors conflating the two is a real risk (see risks).

Late 2027
🎯 Entry Point
Entry 1
$48.96
Current price — already near the 52-week low ($44.88), pre-criticality setupNow (small)
Entry 2PREFERRED
$42–45
At/below 52-week low zone — best pre-catalyst R/R if the sector sentiment shock deepens furtherIf dips
Entry 3
$38.00
Deep capitulation — only on a broader nuclear-sector or macro selloffDeep dip only
✅ Take Profit
TP1
Base — criticality achieved on schedule, modest re-rate
$68.54
+40%
TP2
Bull — clean criticality win + consensus target reached
$86.17
+76%
TP3 🌙
Moon — criticality win + DOE loan-program overhang clears + broad SMR re-rate
$107.71
+120%
🔴 Stop Loss
Tight Stop
Below near-term support / Entry 2 zone — thesis-neutral but tightening
$42
-14.2%
Hard Stop
Below 52-week low breach — criticality delay or fresh negative catalyst
$36
-26.5%
Risk / Reward
From Entry 2 ($43.5 mid) tight stop vs TP2
5.4 : 1
⚠ High R/R but pre-revenue and binary — small size mandatory
📅 Estimate Date
Groves First Criticality
Internal target, not a hard regulatory deadline — could slip into August
~Jul 2026
Binary: achieved / delayed
Aurora Commercial Power
The real revenue inflection point — much further out
Late 2027
Target: late 2027
📈 Stock Timeline
1 snapshot · Jul 14
First snapshot — check back next week
Score
68
Jul 14
TP2 Target
$86.17
Jul 14
Rank
#21
Jul 14
📈 Possible Up % — Scenario Spread
Bear
-25%
$36.72
Base
+40%
$68.54
Bull
+76%
$86.17
Moon
+120%
$107.71
← downsideupside →
🏛️ Fed / Macro Risk — MEDIUM

Assesses how Fed policy / interest rates / inflation affect this stock — LOW = minimal risk, HIGH = proceed with caution

Rate Outlook
Fed holds at 3.50–3.75%, but new Chair Warsh's Jun debut FOMC stripped easing-bias language and 9/18 officials now project a 2026 hike — a pre-revenue, capital-intensive name like Oklo is more exposed to a higher-for-longer path than most.
Inflation
Core PCE just accelerated to 3.4% YoY (May, highest since Oct 2023) — reinforces the hawkish Fed backdrop into the Jul 28-29 FOMC, which sits one week after Oklo's criticality target window.
Sector Impact
HIGH sensitivity to risk appetite specifically — Oklo is high-beta, pre-revenue, and already down 31% YTD on rate/loan-program sentiment rather than fundamentals. A risk-off shock around FOMC week would hit this name harder than the market.
Summary
Fed risk MEDIUM-HIGH for this name specifically — the criticality catalyst is company-specific and can work regardless of the macro tape, but Oklo's pre-revenue balance sheet and recent DOE-loan-program-driven selloff show it's unusually exposed to broad risk-off sentiment into the dense Jul 28-30 FOMC/earnings/PCE week.
🎯 Analyst Targets

Wall Street price targets vs the current price — cross-check our TP levels

Consensus (24 analysts)
Buy$88.63+81%
Consensus (16 analysts, alt. source)
Buy$84.1+72%
Guggenheim (Jun 2026 initiation)
Hold$54.06+10%
current price $48.96
🔍 Similar-Catalyst Comparable Check

Stocks that went through similar catalyst events — calibrate whether the +30%+ target is realistic

OKLO✅ GoodJul 2026
+5%
in 1 day
DOE Documented Safety Analysis Approval (Groves precursor step)
Same-company precedent for a smaller regulatory milestone one step before criticality — modest same-day pop, showing the market treats incremental DOE approvals as good-but-not-explosive news.
SMR✅ GoodJun 2026
+13%
in 1 day
NuScale Power — Paragon safety-system contract (HIPS milestone)
Comparable SMR-sector reaction to a safety/technical milestone — real precedent for how the sector responds to derisking news, useful proxy since Oklo has never achieved criticality before.
OKLO❌ BadJun 2026
-22%
in 30 days
DOE $17.5B large-reactor loan program announcement
The main risk case realized already this cycle — shows the stock's downside sensitivity to adverse DOE/policy signals even with no change to Oklo's own technical progress.
⚡ Optional Layer · Tactical Overlay
🎯 Catalyst Spot Mode

Short-term play around the catalyst (Sep 2026 earnings) only — an optional overlay, not a verdict that ranks equal to the Core Holding.

⚠️

Use this stop-loss set (-14% / -20%) only when trading the earnings spot — not for the core holding (use the -14.2% / -26.5% set above). If you are holding long-term, follow the core set.

📈Pre-Catalyst Run-up Pattern
+5% to +13% same-day pop pattern (see comparables)reaction is same-day on the news, not a multi-week runup

SMR-sector names typically pop on safety/regulatory milestones rather than grinding up beforehand — Oklo's own Jul 1 DSA approval and NuScale's Jun 18 Paragon safety-system contract both triggered same-day jumps rather than sustained pre-event runups.

🎲Historical Post-Catalyst Move
✅ Catalyst Winavg +20%
range: +5% to +35%· Jul 2026 (Oklo) / Jun 2026 (NuScale)
Oklo's own Jul 1, 2026 DSA approval (a smaller precursor step) triggered a modest +4.92% same-day pop; NuScale's comparable Jun 18, 2026 safety-milestone contract triggered +12.67%. Actual first criticality is a bigger, more novel milestone than either precursor — no exact same-company precedent exists yet for 'first ever criticality,' so this range leans on the sector pattern plus some allowance for the larger symbolic weight of the event.
❌ Catalyst Missavg -22%
range: -15% to -25%· Jun 2026
Oklo itself fell ~22% in June 2026 on the DOE large-reactor loan-program news — the closest real precedent for how hard this stock can drop on an adverse sector/company signal, even without an outright criticality failure.
💼Spot Position Sizing
How the recommended % is derived
4%
of portfolio

Speculative sizing — pre-revenue, high-beta, binary near-term catalyst. 4% keeps meaningful upside exposure without over-concentrating in a name that's already demonstrated 30%+ drawdowns on sentiment alone.

🛑Stop Loss · Spot Trade
Spot cut-loss levels — separate from the core holding
Before Catalyst
-14%($42)
Below Entry 2 zone before criticality news = thesis-neutral but momentum turning
After Catalyst (Bad Result)-20%
If criticality is delayed past July with no new date, or DOE signals further large-reactor favoritism, exit
📎 Sources

Generated 2026-07-14 · Not financial advice